These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 7348107)

  • 41. Predicting length of stay in long-term treatment for chemically dependent females.
    Williams MT; Roberts CS
    Int J Addict; 1991 May; 26(5):605-13. PubMed ID: 1938012
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Impact of case management on rural women's quality of life and substance use.
    Passey M; Sheldrake M; Leitch K; Gilmore V
    Rural Remote Health; 2007; 7(3):710. PubMed ID: 17683243
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Sex differences in opioid addiction careers.
    Marsh KL; Simpson DD
    Am J Drug Alcohol Abuse; 1986; 12(4):309-29. PubMed ID: 3826021
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Personality, drug use, and early attrition from substance abuse treatment.
    Stark MJ; Campbell BK
    Am J Drug Alcohol Abuse; 1988; 14(4):475-85. PubMed ID: 3232680
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Psychopathology, treatment completion and 5 years outcome. A prospective study of drug abusers.
    Ravndal E; Vaglum P
    J Subst Abuse Treat; 1998; 15(2):135-42. PubMed ID: 9561953
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Three therapeutic communities for drug abusers: differences in treatment environments.
    Bell MD
    Int J Addict; 1985 Oct; 20(10):1523-31. PubMed ID: 4093212
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Treatment process in the therapeutic community: associations with retention and outcomes among adolescent residential clients.
    Edelen MO; Tucker JS; Wenzel SL; Paddock SM; Ebener P; Dahl J; Mandell W
    J Subst Abuse Treat; 2007 Jun; 32(4):415-21. PubMed ID: 17481465
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Temperament and character dimensions in opiate addicts: comparing subjects who completed inpatient treatment in therapeutic communities vs. incompleters.
    Zoccali R; Muscatello MR; Bruno A; Bilardi F; De Stefano C; Felletti E; Isgrò S; Micalizzi V; Micò U; Romeo A; Meduri M
    Am J Drug Alcohol Abuse; 2007; 33(5):707-15. PubMed ID: 17891663
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Gateway Houses: effectiveness of treatment on criminal behavior.
    Holland S
    Int J Addict; 1978 Apr; 13(3):369-81. PubMed ID: 669861
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The MMPI as a predictor of retention in a therapeutic community for heroin addicts.
    Foureman WC; Parks R; Gardin TH
    Int J Addict; 1981 Jul; 16(5):893-903. PubMed ID: 7327771
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Drug offenders' perceptions of motivation: the role of motivation in rehabilitation and reintegration.
    Gideon L
    Int J Offender Ther Comp Criminol; 2010 Aug; 54(4):597-610. PubMed ID: 19299528
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Psychological change during residence in a rehabilitation centre for female drug misusers. Part I. Drug misusers.
    Bennett G; Rigby K
    Drug Alcohol Depend; 1991 Mar; 27(2):149-57. PubMed ID: 2055163
    [TBL] [Abstract][Full Text] [Related]  

  • 53. A comparison of addict-clients retained and lost to treatment.
    Brown BS; Brewster GW
    Int J Addict; 1973; 8(3):421-6. PubMed ID: 4749899
    [No Abstract]   [Full Text] [Related]  

  • 54. What happened to the ones who dropped out? Outcome in eating disorder patients who complete or prematurely terminate treatment.
    Björk T; Björck C; Clinton D; Sohlberg S; Norring C
    Eur Eat Disord Rev; 2009 Mar; 17(2):109-19. PubMed ID: 19142975
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Follow-up evaluation of treatment of drug abuse during 1969 to 1972.
    Simpson DD; Savage LJ; Lloyd MR
    Arch Gen Psychiatry; 1979 Jul; 36(7):772-80. PubMed ID: 454093
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Antecedents and consequences of cocaine abuse among opioid addicts. A 2.5-year follow-up.
    Kosten TR; Rounsaville BJ; Kleber HD
    J Nerv Ment Dis; 1988 Mar; 176(3):176-81. PubMed ID: 3343591
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Gender differences in Afghan drug-abuse treatment: an assessment of treatment entry characteristics, dropout, and outcomes.
    Abadi MH; Shamblen SR; Courser M; Johnson KW; Thompson K; Young L; Browne T
    Ethn Health; 2015; 20(5):453-73. PubMed ID: 24920072
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The impact of a social network intervention on retention in Belgian therapeutic communities: a quasi-experimental study.
    Soyez V; De Leon G; Broekaert E; Rosseel Y
    Addiction; 2006 Jul; 101(7):1027-34. PubMed ID: 16771894
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Planned versus actual duration of drug abuse treatment. Reconciling observational and experimental evidence.
    McCusker J; Stoddard A; Frost R; Zorn M
    J Nerv Ment Dis; 1996 Aug; 184(8):482-9. PubMed ID: 8752077
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Underreporting of cocaine use at posttreatment follow-up and the measurement of treatment effectiveness.
    Lundy A; Gottheil E; McLellan AT; Weinstein SP; Sterling RC; Serota RD
    J Nerv Ment Dis; 1997 Jul; 185(7):459-62. PubMed ID: 9240365
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.